Pharmaceutical Executive April 19, 2024
Mike Hollan

Rahman discusses the new opportunities that digital twins present to researchers.

Digital twins is an exciting new technology that presents researchers in the life sciences industry with the opportunity to obtain highly detailed sets of data. Abid Rahman, SVP of innovation at EVERSANA, spoke with Pharmaceutical Executive about the new technology and how it can be used.

Pharmaceutical Executive:In the most simplistic of terms, what’s a digital twin and why should pharma and life sciences companies care?
Abid Rahman: Digital twins are virtual replicas of physical objects or processes. Sometimes they are called synthetic clones. These can also be created to be human-like characters, developed through AI-based simulations, that to the naked eye, look like humans.

They are trained to sound,...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Biotechnology, Digital Health, Interview / Q&A, Pharma, Pharma / Biotech, Technology, Trends
How Digital Health and Cryptocurrency are Transforming Modern Therapies
Digital Health Highlights April 2024
Exclusive: Thyme Care launches virtual palliative care program, appoints medical director
Tech Vs Tremors: Digital Health Tools For Tremor Management
M&A: Avel eCare acquires Horizon Virtual

Share This Article